Is High-Density Lipoprotein a Modifiable Treatment Target or Just a Biomarker for Cardiovascular Disease?
JRSM Cardiovascular Disease
doi 10.1177/2048004019869736
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
SAGE Publications